Chancellor Rachel Reeves Plans Targeted Action on Bills in Forthcoming Financial Plan
Treasury head Reeves has announced she is preparing "specific action to deal with cost of living pressures" in the forthcoming Budget.
During an interview with media outlets, she noted that curbing inflation is a collective task of both the administration and the central bank.
The UK's inflation rate is forecast to be the most elevated among the G7 industrialized countries this year and the following year.
Potential Energy Cost Measures
It is understood the government could take action to bring down utility costs, for instance by reducing the present 5% rate of VAT applied on energy supplies.
Another option is to cut some of the government charges currently added to bills.
Budgetary Limitations and Expert Predictions
The administration will obtain the latest draft from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will show how much room there is for such actions.
The consensus from most economists is that the Chancellor will have to declare higher taxes or spending cuts in order to meet her self-imposed borrowing rules.
Earlier on Thursday, estimates indicated there was a £22 billion shortfall for the Treasury chief to fill, which is at the lower end of projections.
"It is a shared responsibility between the Bank of England and the government to continue tackling some of the drivers of inflation," the Chancellor informed the BBC in Washington, at the yearly gatherings of the IMF and global financial institution.
Revenue Commitments and International Issues
While much of the focus has been on likely tax increases, the chancellor said the most recent figures from the OBR had not altered her vow to campaign commitments not to raise tax levels on earnings tax, VAT or social security contributions.
She blamed an "unpredictable world" with increasing geopolitical and trade issues for the fiscal revenue measures, likely to be directed on those "most able to pay."
Global Economic Disputes
Addressing worries about the United Kingdom's trade ties with the Asian nation she said: "Our national security always take priority."
Last week's declaration by China to tighten export controls on rare earths and other materials that are essential for advanced tech production led US President the US President to propose an further 100% tariff on goods from China, increasing the risk of an all-out trade war between the two largest economies.
The US Treasury Secretary described the Chinese decision "economic coercion" and "a international production power grab."
Asked about accepting the American proposal to join its battle with the Asian nation, Reeves said she was "extremely troubled" by China's measures and urged the Beijing authorities "not to put up barriers and limit trade."
She said the action was "harmful for the international commerce and causes additional headwinds."
"It is my opinion there are areas where we need to challenge Chinese policies, but there are also valuable opportunities to export to Chinese markets, including financial services and other sectors of the economy. We've got to achieve that balance correct."
The Treasury chief also stated she was collaborating with G7 counterparts "regarding our own essential resources plan, so that we are reduced dependence."
Health Service Drug Costs and Funding
Reeves also acknowledged that the cost the National Health Service spends on drugs could go up as a result of current negotiations with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and funding.
Some of the world's largest drug companies have said in recent statements that they are either halting or scrapping operations in the United Kingdom, with several blaming the modest returns they are obtaining.
Last month, the government science advisor said the cost the health service pays for drugs would need to increase to stop companies and drug research funding leaving the UK.
Reeves informed media: "We have seen due to the pricing regime, that drug testing, innovative medicines have not been available in the United Kingdom in the extent that they are in other European countries."
"We want to make sure that patients receiving treatment from the NHS are can receive the top critical treatments in the globe. And so we are looking at this situation, and... aiming to obtain increased investment into Britain."